Literature DB >> 2910445

Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.

J E Montie1, D P Wood, J E Pontes, J M Boyett, H S Levin.   

Abstract

The prostate glands of 84 men undergoing cystoprostatectomy for bladder cancer were examined by whole-mount sections at 4-mm to 5-mm intervals to identify unsuspected prostate adenocarcinoma (PCa). Of 72 white patients with entirely normal digital rectal examinations (DRE), 33 (46%) were found to have PCa, including 12 (17%) who had a Gleason score of 6 or greater and seven (10%) who had penetration through the prostatic capsule. These observations are consistent with previous studies in autopsy populations but allow a more appropriate comparison with morphologic data generated from radical prostatectomy specimens. If these data can be extended to the age-matched general population, treatment at a 1% mortality rate for all white men 60 to 74 years of age with a PCa with a Gleason score of 6 or greater could cause between 6190 and 30,951 deaths, in contrast to 7335 deaths expected from the cancer. These data stress the need for a control group in a study designed to evaluate the benefit of early diagnosis and treatment of PCa.

Entities:  

Mesh:

Year:  1989        PMID: 2910445     DOI: 10.1002/1097-0142(19890115)63:2<381::aid-cncr2820630230>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

Review 1.  The androgen receptor and stem cell pathways in prostate and bladder cancers (review).

Authors:  Katarzyna Marcinkiewicz; Kymora B Scotland; Stephen A Boorjian; Emeli M Nilsson; Jenny Liao Persson; Per Anders Abrahamsson; Cinzia Allegrucci; Ieuan A Hughes; Lorraine J Gudas; Nigel P Mongan
Journal:  Int J Oncol       Date:  2011-09-28       Impact factor: 5.650

2.  Should Canadians be offered systematic prostate cancer screening? No.

Authors:  Michel Labrecque; France Légaré; Michel Cauchon
Journal:  Can Fam Physician       Date:  2007-06       Impact factor: 3.275

Review 3.  Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

4.  The case for prostate capsule-sparing radical cystectomy in selected patients.

Authors:  Laurence Klotz; Jehonathan Pinthus
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

5.  Prostate capsule sparing radical cystectomy: oncologic safety and clinical outcome.

Authors:  Laurence Klotz
Journal:  Ther Adv Urol       Date:  2009-04

6.  Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens.

Authors:  H M Fritsche; A Aziz; F Eder; W Otto; S Denzinger; W F Wieland; M May; F Hofstädter; A Hartmann; M Burger
Journal:  Virchows Arch       Date:  2012-10-09       Impact factor: 4.064

7.  Characterization of prostate cancer incidentally detected in radical cystoprostatectomy specimens from Japanese men with bladder cancer.

Authors:  Toshifumi Kurahashi; Hideaki Miyake; Junya Furukawa; Masafumi Kumano; Atsushi Takenaka; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2009-05-16       Impact factor: 2.370

8.  Novel diagnostic biomarkers for prostate cancer.

Authors:  Chikezie O Madu; Yi Lu
Journal:  J Cancer       Date:  2010-10-06       Impact factor: 4.207

9.  Prostate cancer trends in Canada: rising incidence or increased detection?

Authors:  I G Levy; L Gibbons; J P Collins; D G Perkins; Y Mao
Journal:  CMAJ       Date:  1993-09-01       Impact factor: 8.262

10.  Incidental prostate cancer in patients undergoing radical cystoprostatectomy for bladder cancer.

Authors:  Mustafa Hiros; Hajrudin Spahović; Mirsad Selimović; Sabina Sadović
Journal:  Bosn J Basic Med Sci       Date:  2008-05       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.